After graduating as a pharmacist in 2008 he joined CycloLab in 2011. He has attended further studies in pharmaceutical economy, pharmaceutical quality assurance and is a licensed Qualified Person. He defended his PhD thesis in 2012 in pharmaceutical chemistry at Semmelweis University (Budapest). At CycloLab he has been the head of Quality Control (2013-2017) and the head of Research and Development, supervisor of all R&D projects, including the ones, where USP N.F. and EP grade Sulfobutyl-ether-beta-cyclodextrin is applied (2017-2020). From 2017, he is a member of the management, since 2019 as an executive. As of January 1, 2021 he is appointed as CEO of the company. He is working as a specialist in the Working Party of Carbohydrates of the European Directorate for the Quality of Medicines and Health Care (EDQM). He is author or co-author of over 40 scientific papers and 60 conference presentations and 5 patents/patent applications.